Millions of people around the world live with type 2 diabetes, a condition in which the body cannot use insulin properly and blood sugar stays too high. Over time, high blood sugar can damage the heart, kidneys, eyes, and nerves.
Because of this, many people need medicine to help keep their blood sugar under control. One of these medicines is rosiglitazone, a drug that has been available for many years. While it can lower blood sugar, doctors have long questioned whether it may also increase the risk of serious heart problems.
A new study led by researchers from the Yale School of Public Health and several other research institutions has added important new evidence to this debate. The research was published in the BMJ (British Medical Journal).
After carefully reviewing information from more than 130 clinical trials involving over 48,000 adults who took rosiglitazone for at least 24 weeks, the team found that people taking the drug had a higher chance of developing major heart-related problems.
Rosiglitazone belongs to a family of diabetes medicines called thiazolidinediones. These medicines help the body’s cells respond better to insulin so that sugar can move from the blood into the cells more easily.
When the drug first became available, it was considered an important treatment option for people with type 2 diabetes. However, concerns about its safety began to grow after reports suggested it might increase the risk of heart attacks and heart failure.
Because of these concerns, European regulators suspended the medicine, while authorities in the United States placed strict limits on its use for a period of time.
Scientists continued to investigate the drug, but many earlier studies produced different answers. One reason was that researchers often did not have access to detailed information about each patient, making it harder to fully understand the medicine’s true safety.
The new investigation is one of the largest and most detailed studies ever carried out on rosiglitazone. Instead of looking only at summary results, the researchers examined detailed information from individual patients whenever possible.
This allowed them to compare people taking rosiglitazone with those receiving another diabetes medicine or a placebo, which is a treatment with no active drug.
The results showed that people using rosiglitazone had a 33% higher risk of experiencing serious heart-related events. These events included heart attacks, heart failure, and death from heart disease or other causes.
Among 11,837 people taking rosiglitazone, there were 274 serious heart events. In comparison, 219 similar events occurred among 9,319 people in the comparison groups.
The researchers said these findings show why it is so important for scientists to have access to detailed patient information when checking the safety of medicines. Better access to clinical trial data can help reveal problems that may not be obvious when only summary results are available.
They also encouraged greater openness in medical research so doctors, patients, and health authorities can make better-informed decisions.
The findings do not mean that everyone taking rosiglitazone will develop heart disease. Many people have used the medicine without experiencing these problems. However, the study suggests that the overall risk is higher than previously thought.
Anyone currently taking rosiglitazone should not stop the medicine on their own, because suddenly changing diabetes treatment can lead to poor blood sugar control. Instead, patients should speak with their doctor to discuss whether another medicine may be a safer option based on their own health and medical history.
Today, many newer diabetes medicines are available, and some have even been shown to protect the heart as well as lower blood sugar. This makes careful discussion between patients and healthcare providers even more important when choosing the best treatment.
The new research highlights how medicine safety must continue to be monitored even after drugs have been approved and widely used. As scientists collect better information and share data more openly, doctors can make more confident decisions and patients can receive treatments that are both effective and as safe as possible.
If you care about diabetes, please read studies about bananas and diabetes, and honey could help control blood sugar.
For more health information, please see recent studies about Vitamin D that may reduce dangerous complications in diabetes and plant-based protein foods may help reverse type 2 diabetes.
Copyright © 2026 Knowridge Science Report. All rights reserved.
